ANALGESIC EFFECTS INDUCED BY THE AGONIST OF CANNABINOID TYPE 2 (CB2) RECEPTORS, AM1241, IN A MURINE MODEL OF BONE CANCER PAIN

被引：0
|
作者：
Curto-Reyes, V. [1 ]
Llames, S.
Hidalgo, A. [1 ]
Menendez, L. [1 ]
Baamonde, A. [1 ]
机构：
[1] Univ Oviedo, Area Farmacol, Dept Med, Asturias, Spain
来源：
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2008年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：85 / 85
页数：1
相关论文
共 50 条
  • [41] MEAD ETHANOLAMIDE, A NOVEL EICOSANOID, IS AN AGONIST FOR THE CENTRAL (CB1) AND PERIPHERAL (CB2) CANNABINOID RECEPTORS
    PRILLER, J
    BRILEY, EM
    MANSOURI, J
    DEVANE, WA
    MACKIE, K
    FELDER, CC
    [J]. MOLECULAR PHARMACOLOGY, 1995, 48 (02) : 288 - 292
  • [42] Effects of CB2 receptor agonist palmitoylethanolamide and CB2 receptor antagonist AM 630 on leucocyte phagocytic activity in mice
    Vinklerová, J
    Sulcová, A
    [J]. BEHAVIOURAL PHARMACOLOGY, 2002, 13 (5-6): : 507 - 508
  • [43] Involvement of Spinal Cannabinoid CB2 Receptors in Exercise-Induced Antinociception
    dos Santos, Rafaela Silva
    Sorgi, Carlos Arterio
    Ferranti Peti, Ana Paula
    Veras, Flavio Protasio
    Faccioli, Lucia Helena
    Galdino, Giovane
    [J]. NEUROSCIENCE, 2019, 418 : 177 - 188
  • [44] Role of CB2 Cannabinoid Receptors in the Rewarding, Reinforcing, and Physical Effects of Nicotine
    Navarrete, Francisco
    Rodriguez-Arias, Marta
    Martin-Garcia, Elena
    Navarro, Daniela
    Garcia-Gutierrez, Maria S.
    Aguilar, Maria A.
    Aracil-Fernandez, Auxiliadora
    Berbel, Pere
    Minarro, Jose
    Maldonado, Rafael
    Manzanares, Jorge
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 (12) : 2515 - 2524
  • [45] CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity
    Onaivi, Emmanuel S.
    Ishiguro, Hiroki
    Gu, Shanzhi
    Liu, Qing-Rong
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (01) : 92 - 103
  • [46] Review -: New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptors
    Gertsch, Juerg
    Raduner, Stefan
    Altmann, Karl-Heinz
    [J]. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2006, 26 (5-6) : 709 - 730
  • [47] Role of CB2 Cannabinoid Receptors in the Rewarding, Reinforcing, and Physical Effects of Nicotine
    Francisco Navarrete
    Marta Rodríguez-Arias
    Elena Martín-García
    Daniela Navarro
    María S García-Gutiérrez
    María A Aguilar
    Auxiliadora Aracil-Fernández
    Pere Berbel
    José Miñarro
    Rafael Maldonado
    Jorge Manzanares
    [J]. Neuropsychopharmacology, 2013, 38 : 2515 - 2524
  • [48] BENEFICIAL PARACRINE EFFECTS OF CANNABINOID CB2 RECEPTORS ON LIVER INJURY AND REGENERATION
    Teixeira-Clerc, F.
    Belot, M. -P.
    Manin, S.
    Deveaux, V.
    Zimmer, A.
    Tordjmann, T.
    Mallat, A.
    Lotersztajn, S.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S382 - S382
  • [49] Partial agonist-inverse agonist behaviour of 6′-azidohex-2′-yneΔ8-tetrahydrocannabinol at cannabinoid CB and CB2 receptors
    Gibson, TM
    Stevenson, LA
    Ross, RA
    Saha, B
    Razdan, RK
    Pertwee, RG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128
  • [50] In vitro and in vivo characterization of A-796260:: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models
    Yao, B. B.
    Hsieh, G. C.
    Frost, J. M.
    Fan, Y.
    Garrison, T. R.
    Daza, A. V.
    Grayson, G. K.
    Zhu, C. Z.
    Pai, M.
    Chandran, P.
    Salyers, A. K.
    Wensink, E. J.
    Honore, P.
    Sullivan, J. P.
    Dart, M. J.
    Meyer, M. D.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (02) : 390 - 401
12345